arrow
I

Ichiro Ota

otolaryngology-head and neck surgery
H指数:38
被引数:7,554

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a novel prognostic assessment tool for recurrent respiratory papillomatosis

开发一种新型复发性呼吸道乳头状瘤病预后评估工具

2026-04-160
OAAI
A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer

一项关于纳武利尤单抗治疗铂类耐药的复发性或转移性唾液腺癌患者的II期临床试验

2025-12-010
OA
Zinc finger domains bind low-complexity domain polymers

锌指结构域结合低复杂性结构域聚合物

2025-10-160
OAAI
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)

通过综合分析头颈癌患者的预处理血浆外泌体mrna,鉴定生物标志物以预测nivolumab的治疗反应的全国多中心前瞻性研究 (BIONEXT研究)

2025-01-100
OAAI
Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving Chemoradiation
2021-11-0117
OAAI
Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national head and neck cancer registry of Japan

p16-positive口咽鳞状细胞癌治疗策略的优化: 基于日本国家头颈癌登记的多机构观察性研究

CANCER
IF5.1
2020-07-1021
OAAI
Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study
2017-05-0528
OAAI
Lymph Node Metastasis in T4 Maxillary Sinus Squamous Cell Carcinoma: Incidence and Treatment Outcome
2014-02-2030
PRE